In previous studies we identified that activation of the cell-transforming HER2 oncogene causes induction of intracellular reactive oxygen species (ROS) and activation of redox signaling that impinges on a variety of cancer cell pathways8, 9. This evidence concerns the gene ERBB2 and cancer.